Who
Kevin Rakin
Director and 10% owner
Company insider
Files Form 4 as: Director and 10% owner, Elutia; Director, Quantum-Si; Director, Oramed Pharmaceuticals; Director, Ocugen; Director, Vion Pharmaceuticals; Director, Omrix Biopharmaceuticals; Director, Clinical Data.
In numbers
- Trades disclosed
- 119
- Buys
- 5
- Sells
- 5
- Bought
- $323K
- Sold
- $890K
- Companies
- 7
- Companies where not an officer
- 7
- First trade
- 12 May 2006
- Last trade
- 11 Jun 2026
- Last filed
- 15 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 11 Jun 2026filed 15 Jun 2026 | ELUT Elutiaoption or derivative · Biotechnology | SEC FORM 4 Code A | —159,590 at $0.00 | filing |
| 11 Jun 2026filed 15 Jun 2026 | ELUT Elutiaoption or derivative · Biotechnology | SEC FORM 4 Code A | —159,590 at $0.00 | filing |
| 1 Jun 2026filed 2 Jun 2026 | ELUT ElutiaBiotechnology | SEC FORM 4 Code G | —70,000 at $0.00 | filing |
| 1 Jun 2026filed 2 Jun 2026 | ELUT ElutiaBiotechnology | SEC FORM 4 Code J | —50,000 at $0.00 | filing |
| 18 May 2026filed 20 May 2026 | QSI Quantum-Sioption or derivative · Life-science tools | SEC FORM 4 Code A | —251,185 at $0.00 | filing |
| 18 May 2026filed 20 May 2026 | QSI Quantum-Sioption or derivative · Life-science tools | SEC FORM 4 Code A | —251,185 at $0.00 | filing |
| 30 Jan 2026filed 2 Feb 2026 | ELUT ElutiaBiotechnology | SEC FORM 4 Bought | $74K70,000 at $1.06 | filing |
| 30 Jan 2026filed 2 Feb 2026 | ELUT ElutiaBiotechnology | SEC FORM 4 Bought | $74K70,000 at $1.06 | filing |
| 11 Dec 2025filed 17 Dec 2025 | ELUT ElutiaBiotechnology | SEC FORM 4 Code J | —4,505,941 | filing |
| 11 Dec 2025filed 15 Dec 2025 | ELUT ElutiaBiotechnology | SEC FORM 4 Code J | —4,372,497 | filing |
| 29 May 2025filed 2 Jun 2025 | ELUT Elutiaoption or derivative · Biotechnology | SEC FORM 4 Code A | —90,509 at $0.00 | filing |
| 19 May 2025filed 21 May 2025 | QSI Quantum-Sioption or derivative · Life-science tools | SEC FORM 4 Code A | —126,095 at $0.00 | filing |
| 6 Jun 2024filed 10 Jun 2024 | ELUT Elutiaoption or derivative · Biotechnology | SEC FORM 4 Code A | —47,753 at $0.00 | filing |
| 16 May 2024filed 17 May 2024 | QSI Quantum-Sioption or derivative · Life-science tools | SEC FORM 4 Code A | —113,281 at $0.00 | filing |
| 12 May 2023filed 16 May 2023 | QSI Quantum-Sioption or derivative · Life-science tools | SEC FORM 4 Code A | —120,481 at $0.00 | filing |
| 20 Dec 2022filed 22 Dec 2022 | QSI Quantum-SiLife-science tools | SEC FORM 4 Code J | —601,000 at $0.00 | filing |
| 15 Dec 2022filed 16 Dec 2022 | QSI Quantum-SiLife-science tools | SEC FORM 4 Sold | $191K89,000 at $2.15 | filing |
| 11 May 2022filed 13 May 2022 | QSI Quantum-Sioption or derivative · Life-science tools | SEC FORM 4 Code A | —59,880 at $0.00 | filing |
| 21 Mar 2022filed 22 Mar 2022 | ORMP Oramed PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $94K10,000 at $9.41 | filing |
| 17 Feb 2022filed 22 Feb 2022 | ORMP Oramed Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code M | —6,667 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.